Exelixis
NASDAQ: EXEL
$16.79
-$0.15 (-0.9%)
Closing price November 28, 2022
Thursday's top analyst upgrades and downgrades included AT&T, Alibaba, Ally Financial, BioMarin Pharmaceutical, Box, Citrix Systems, Nio, Schlumberger and TJX Companies.
1 year ago
Last Updated: 1 year ago
Tuesday’s top analyst upgrades and downgrades included Campbell Soup, Exact Sciences, Exelixis, Pool, Spirit Airlines and ZTO Express.
1 year ago
Last Updated: 1 year ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including BioNTech, Denali Therapeutics, Exelixis, Foot Locker and Hostess Brands.
1 year ago
Last Updated: 1 year ago
Thursday's top analyst upgrades and downgrades included Adobe, Baker Hughes, Best Buy, Cisco Systems, CyberArk Software, Enphase Energy, Grubhub, Jumia Technologies, SmileDirectClub, Under Armour and...
2 years ago
Last Updated: 2 years ago
Exelixis stock jumped early on Monday after the company, in conjunction with Bristol-Myers Squibb, announced positive late-stage results from its kidney cancer study.
2 years ago
The top analyst upgrades, downgrades and initiations seen on Monday included Chipotle Mexican Grill, Delphi Technologies, Dollar General, Facebook, Ingersoll-Rand, Nike, Okta and Quest Diagnostics.
3 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, United Technologies and...
3 years ago
Last Updated: 2 years ago
The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies post quarterly results that beat top-line Wall Street expectations.
3 years ago
Last Updated: 2 years ago
Sears, Weyerhaeuser, Laredo Petroleum, and Exelixis were among the stocks posting new 52-week lows Monday.
4 years ago
Last Updated: 2 years ago
Exelixis shares dipped on Monday after the company announced that it has initiated a late-stage trial in patients with radioiodine-refractory differentiated thyroid cancer (DTC).
4 years ago
Last Updated: 2 years ago
JD.com, Turquoise Hills, Exelixis, and Floor & Decor Holdings all posted new 52-week lows Monday.
4 years ago
Last Updated: 2 years ago
Invesco, Tal Education, Chemours, and Exelixis all posted new 52-week lows on Thursday.
4 years ago
Last Updated: 1 year ago
SeaChange, Sears, Exelixis, and Adamis Pharma all posted new 52-week lows Tuesday.
4 years ago
Last Updated: 2 years ago
Lannett Co., Scorpio Tankers, Mobile Telesystems, and Exelixis all posted new 52-week lows Monday.
4 years ago
Last Updated: 2 years ago
These four top Suntrust biotech picks for 2018 all have the potential for big upside moves if they do indeed exceed first-quarter expectations.
4 years ago
Last Updated: 2 years ago